Literature DB >> 9526550

B-cell epitopes of varicella-zoster virus glycoprotein II.

A Kjartansdóttir1, E Lycke, S R Norrby.   

Abstract

B-cell epitopes of varicella-zoster virus glycoprotein II were mapped by means of solid phase ELISA, synthetic oligopeptides (constructed according to the Davison-Scott sequencing of the varicella-zoster virus genome) and sera from varicellae and herpes zoster patients. The individual pattern of antibody peptide binding varied considerably but at least 9 more reactive sites seemed discernible. A 31-mer-peptide corresponding to a hydrophilic segment of the glycoprotein (aa 417-447) was constructed. This peptide reacted with 2 out of 4 varicellae and 5 out of 9 zoster sera, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9526550     DOI: 10.1007/bf01718644

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  12 in total

Review 1.  Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking.

Authors:  C Grose
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

Review 2.  Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs.

Authors:  C Grose
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

3.  Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.

Authors:  V A Sundqvist; A Linde; B Wahren
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

4.  Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes of plaque morphology and neuropathogenicity.

Authors:  K Weise; H C Kaerner; J Glorioso; C H Schröder
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

5.  Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus.

Authors:  P M Keller; A J Davison; R S Lowe; C D Bennett; R W Ellis
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

6.  Neuroinvasion by herpes simplex virus. An in vitro model for characterization of neurovirulent strains.

Authors:  T Bergström; E Lycke
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

7.  T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.

Authors:  A R Hayward
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox.

Authors:  A K Junker; P Tilley
Journal:  J Med Virol       Date:  1994-06       Impact factor: 2.327

9.  Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.

Authors:  M Massaer; M Haumont; M Place; A Bollen; P Jacobs
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

10.  Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies.

Authors:  T Bergström; E Sjögren-Jansson; S Jeansson; E Lycke
Journal:  Mol Cell Probes       Date:  1992-02       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.